MedPath

A Questionnaire Survey Study for Exploring Outcomes for Patients With Disc Herniation

Completed
Conditions
Lumbar Disc Herniation
Interventions
Other: No intervention
Registration Number
NCT05752838
Lead Sponsor
Jaseng Medical Foundation
Brief Summary

Background: The selection of primary outcomes that reflect the real symptoms and conditions of patients is instrumental in clinical studies on the effectiveness of specific treatment modalities. This study aimed to explore the appropriate outcomes that reflect the real-world needs and concerns of patients with lumbar disc herniation (LDH) and provide a basis for designing related clinical trials.

Methods and Findings: This cross-sectional nationwide web-based survey study was conducted in South Korea in November 2022. Patients who were diagnosed with LDH and had LDH-related radiating leg pain were enrolled. The questionnaire consisted of 5 parts: basic characteristics, disease onset, symptom and severity, priority symptoms for improvement, and important factors in treatment. Overall, 500 patients (100 patients from the each age group) were enrolled.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  • diagnosed of LDH
  • age 19-69 years
  • presence of LDH-related symptoms such as pain, numbness, weakness, or tingling in the legs
  • agree to informed consent form
Exclusion Criteria
  • severe mental illness and intellectual disabilities that prevented independence in answering the questionnaire

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Diagnosed with LDH and had LDH-related radiating leg painNo intervention-
Primary Outcome Measures
NameTimeMethod
survey basic characteristics1 day
symptom and its severity survey1 day
disease onset survey1 day
priority symptoms for improvement survey1 day
important factors in treatment survey1 day
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Jaseng Medical Foundation

🇰🇷

Seoul, Gangnam-gu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath